We made incredible strides last year — it's all in our 2018 Year in Review.
Gilead launches the COMPASS Initiative™ to help address the HIV/AIDS epidemic in the Southern United States.
Supporting Elimination Efforts.
With the emergence of new therapies that have transformed chronic HCV treatment, it is now possible to eliminate the disease in certain populations.
We strive to help improve the lives of people with life-threatening illnesses around the world by giving them access to the medicine they need.